| Title |
Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial / |
| Authors |
Lutsar, Irja ; Trafojer, Ursula M. T ; Heath, Paul T ; Metsvaht, Tuuli ; Standing, Joseph ; Esposito, Susanna ; de Cabre, Vincent Meiffredy ; Oeser, Clarissa ; Aboulker, Jean-Pierre |
| DOI |
10.1186/1745-6215-12-215 |
| Full Text |
|
| Is Part of |
Trials.. London : BioMed Central Ltd. 2011, Vol. 12, art. no. 215, [9 p.].. ISSN 1745-6215 |
| Keywords [eng] |
neonatal ; sepsis ; therapy |
| Abstract [eng] |
Late onset neonatal sepsis (LOS) with the mortality of 17 to 27% is still a serious disease. Meropenem is an antibiotic with wide antibacterial coverage. The advantage of it over standard of care could be its wider antibacterial coverage and thus the use of mono-instead of combination therapy. |
| Published |
London : BioMed Central Ltd |
| Type |
Journal article |
| Language |
English |
| Publication date |
2011 |
